Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
David Rescott is an analyst at Baird. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/18/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 03/18/2025 | ISRG | Buy Now | Intuitive Surgical | $482.48 | 24.36% | David Rescott58% | $707 → $600 | Maintains | Outperform | Get Alert |
| 02/19/2025 | PEN | Buy Now | Penumbra | $273.04 | 19.03% | David Rescott58% | $285 → $325 | Maintains | Buy | Get Alert |
| 02/19/2025 | PEN | Buy Now | Penumbra | $273.04 | 20.13% | David Rescott58% | $305 → $328 | Maintains | Outperform | Get Alert |
| 02/19/2025 | MDT | Buy Now | Medtronic | $92.36 | -1.47% | David Rescott58% | $90 → $91 | Maintains | Neutral | Get Alert |
| 01/23/2025 | PEN | Buy Now | Penumbra | $273.04 | 11.71% | David Rescott58% | $275 → $305 | Maintains | Outperform | Get Alert |
| 01/07/2025 | NARI | Buy Now | Inari Medical | — | — | David Rescott58% | $81 → $80 | Downgrade | Outperform → Neutral | Get Alert |
| 11/20/2024 | MDT | Buy Now | Medtronic | $92.36 | 0.69% | David Rescott58% | $96 → $93 | Maintains | Neutral | Get Alert |
| 10/31/2024 | PEN | Buy Now | Penumbra | $273.04 | -12.1% | David Rescott58% | $235 → $240 | Maintains | Buy | Get Alert |
| 10/31/2024 | PEN | Buy Now | Penumbra | $273.04 | -9.17% | David Rescott58% | $244 → $248 | Maintains | Outperform | Get Alert |
| 10/31/2024 | MMSI | Buy Now | Merit Medical Systems | $99.95 | 9.05% | David Rescott58% | $107 → $109 | Maintains | Outperform | Get Alert |
| 10/31/2024 | LIVN | Buy Now | LivaNova | $40.41 | 78.17% | David Rescott58% | $66 → $72 | Maintains | Outperform | Get Alert |
| 10/29/2024 | NARI | Buy Now | Inari Medical | — | — | David Rescott58% | $66 → $67 | Maintains | Outperform | Get Alert |
| 10/25/2024 | EW | Buy Now | Edwards Lifesciences | $70.34 | -3.33% | David Rescott58% | $73 → $68 | Maintains | Neutral | Get Alert |
| 10/18/2024 | ISRG | Buy Now | Intuitive Surgical | $482.48 | 17.1% | David Rescott58% | $503 → $565 | Maintains | Outperform | Get Alert |
| 10/15/2024 | PEN | Buy Now | Penumbra | $273.04 | -10.64% | David Rescott58% | $180 → $244 | Maintains | Outperform | Get Alert |
| 09/17/2024 | LIVN | Buy Now | LivaNova | $40.41 | 63.33% | David Rescott58% | $55 → $66 | Upgrade | Neutral → Outperform | Get Alert |
| 08/21/2024 | MDT | Buy Now | Medtronic | $92.36 | -2.56% | David Rescott58% | $82 → $90 | Maintains | Neutral | Get Alert |
| 07/31/2024 | PEN | Buy Now | Penumbra | $273.04 | -34.08% | David Rescott58% | $231 → $180 | Maintains | Outperform | Get Alert |
| 07/31/2024 | NARI | Buy Now | Inari Medical | — | — | David Rescott58% | $65 → $63 | Maintains | Outperform | Get Alert |
| 07/25/2024 | BSX | Buy Now | Boston Scientific | $99.22 | -8.28% | David Rescott58% | $90 → $91 | Maintains | Outperform | Get Alert |
| 07/25/2024 | EW | Buy Now | Edwards Lifesciences | $70.34 | -0.48% | David Rescott58% | $102 → $70 | Downgrade | Outperform → Neutral | Get Alert |
| 07/16/2024 | PEN | Buy Now | Penumbra | $273.04 | -15.4% | David Rescott58% | $267 → $231 | Maintains | Outperform | Get Alert |
| 06/28/2024 | MMSI | Buy Now | Merit Medical Systems | $99.95 | -3.95% | David Rescott58% | → $96 | Initiates | → Outperform | Get Alert |
| 04/25/2024 | BSX | Buy Now | Boston Scientific | $99.22 | -15.34% | David Rescott58% | $79 → $84 | Maintains | Outperform | Get Alert |
| 04/17/2024 | PEN | Buy Now | Penumbra | $273.04 | -2.21% | David Rescott58% | $291 → $267 | Maintains | Neutral | Get Alert |
| 02/23/2024 | PEN | Buy Now | Penumbra | $273.04 | 6.21% | David Rescott58% | $300 → $290 | Maintains | Buy | Get Alert |
| 01/26/2024 | PEN | Buy Now | Penumbra | $273.04 | 9.87% | David Rescott58% | $295 → $300 | Maintains | Buy | Get Alert |
| 01/16/2024 | AXNX | Buy Now | Axonics | — | — | David Rescott58% | $73 → $71 | Downgrade | Buy → Hold | Get Alert |
| 01/12/2024 | AXNX | Buy Now | Axonics | — | — | David Rescott58% | $73 → $71 | Downgrade | Buy → Hold | Get Alert |
| 12/22/2023 | SIBN | Buy Now | SI-BONE | $14.79 | 75.79% | David Rescott58% | $25 → $26 | Maintains | Buy | Get Alert |
| 12/22/2023 | PEN | Buy Now | Penumbra | $273.04 | 8.04% | David Rescott58% | $265 → $295 | Maintains | Buy | Get Alert |
| 12/22/2023 | AXNX | Buy Now | Axonics | — | — | David Rescott58% | $65 → $73 | Maintains | Buy | Get Alert |
| 12/12/2023 | PEN | Buy Now | Penumbra | $273.04 | -2.94% | David Rescott58% | $240 → $265 | Maintains | Buy | Get Alert |
| 11/03/2023 | PEN | Buy Now | Penumbra | $273.04 | -11% | David Rescott58% | $247 → $243 | Maintains | Outperform | Get Alert |
| 10/17/2023 | PEN | Buy Now | Penumbra | $273.04 | -9.54% | David Rescott58% | $375 → $247 | Maintains | Outperform | Get Alert |
| 09/21/2023 | BSX | Buy Now | Boston Scientific | $99.22 | -36.5% | David Rescott58% | $60 → $63 | Maintains | Outperform | Get Alert |
| 08/08/2023 | SIBN | Buy Now | SI-BONE | $14.79 | 109.6% | David Rescott58% | $33 → $31 | Maintains | Buy | Get Alert |
| 08/02/2023 | PEN | Buy Now | Penumbra | $273.04 | 26.36% | David Rescott58% | $370 → $345 | Maintains | Buy | Get Alert |
| 07/28/2023 | AXNX | Buy Now | Axonics | — | — | David Rescott58% | $69 → $70 | Maintains | Outperform | Get Alert |
| 07/27/2023 | LIVN | Buy Now | LivaNova | $40.41 | 53.43% | David Rescott58% | $56 → $62 | Maintains | Outperform | Get Alert |
| 07/19/2023 | SIBN | Buy Now | SI-BONE | $14.79 | 123.12% | David Rescott58% | $28 → $33 | Maintains | Buy | Get Alert |
| 07/19/2023 | PEN | Buy Now | Penumbra | $273.04 | 35.51% | David Rescott58% | $350 → $370 | Maintains | Buy | Get Alert |
| 07/19/2023 | BSX | Buy Now | Boston Scientific | $99.22 | -40.54% | David Rescott58% | → $59 | Initiates | → Outperform | Get Alert |
| 07/19/2023 | EW | Buy Now | Edwards Lifesciences | $70.34 | 52.12% | David Rescott58% | → $107 | Initiates | → Outperform | Get Alert |
| 07/19/2023 | MDT | Buy Now | Medtronic | $92.36 | -2.56% | David Rescott58% | → $90 | Initiates | → Neutral | Get Alert |
| 07/19/2023 | NARI | Buy Now | Inari Medical | — | — | David Rescott58% | → $79 | Initiates | → Outperform | Get Alert |
| 07/19/2023 | PEN | Buy Now | Penumbra | $273.04 | 37.34% | David Rescott58% | → $375 | Initiates | → Outperform | Get Alert |
| 07/19/2023 | AXNX | Buy Now | Axonics | — | — | David Rescott58% | → $69 | Initiates | → Outperform | Get Alert |
| 05/18/2023 | PEN | Buy Now | Penumbra | $273.04 | 28.19% | David Rescott58% | $320 → $350 | Maintains | Buy | Get Alert |
| 04/17/2023 | AXNX | Buy Now | Axonics | — | — | David Rescott58% | $82 → $73 | Maintains | Buy | Get Alert |
| 02/28/2023 | SIBN | Buy Now | SI-BONE | $14.79 | 75.79% | David Rescott58% | $21 → $26 | Maintains | Buy | Get Alert |
| 01/30/2023 | PEN | Buy Now | Penumbra | $273.04 | 4.01% | David Rescott58% | $255 → $284 | Maintains | Buy | Get Alert |
| 12/20/2022 | SIBN | Buy Now | SI-BONE | $14.79 | 14.94% | David Rescott58% | $20 → $17 | Maintains | Buy | Get Alert |
| 12/20/2022 | PEN | Buy Now | Penumbra | $273.04 | -6.61% | David Rescott58% | $228 → $255 | Maintains | Buy | Get Alert |
| 12/20/2022 | AXNX | Buy Now | Axonics | — | — | David Rescott58% | $90 → $82 | Maintains | Buy | Get Alert |
| 11/01/2022 | AXNX | Buy Now | Axonics | — | — | David Rescott58% | $80 → $90 | Maintains | Buy | Get Alert |
| 09/13/2022 | PEN | Buy Now | Penumbra | $273.04 | -15.76% | David Rescott58% | $180 → $230 | Maintains | Buy | Get Alert |
| 07/20/2022 | PEN | Buy Now | Penumbra | $273.04 | -34.08% | David Rescott58% | $240 → $180 | Maintains | Buy | Get Alert |
| 02/23/2022 | PEN | Buy Now | Penumbra | $273.04 | 9.87% | David Rescott58% | $350 → $300 | Maintains | Buy | Get Alert |
| 12/21/2021 | SIBN | Buy Now | SI-BONE | $14.79 | 102.84% | David Rescott58% | $35 → $30 | Maintains | Buy | Get Alert |
| 09/22/2021 | PEN | Buy Now | Penumbra | $273.04 | 28.19% | David Rescott58% | $350 → $350 | Maintains | Buy | Get Alert |
| 09/16/2021 | PEN | Buy Now | Penumbra | $273.04 | 28.19% | David Rescott58% | → $350 | Initiates | → Buy | Get Alert |
